Literature DB >> 9844777

Circulating soluble CD30 levels in primary Sjögren's syndrome, SLE and rheumatoid arthritis.

Y Ichikawa, M Yoshida, C Yamada, T Horiki, Y Hoshina, M Uchiyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844777

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  2 in total

1.  Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis.

Authors:  Hasan Ulusoy; Ayhan Kamanli; Necip Ilhan; Omer Kuru; Sule Arslan; Gokhan Alkan; Salih Ozgocmen
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

2.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.